Cancer and Metastasis Reviews

Papers
(The H4-Index of Cancer and Metastasis Reviews is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Editorial Expression of Concern: Targeting microRNAs as a promising anti-cancer therapeutic strategy against traffic-related air pollution-mediated lung cancer229
Immunotherapy for leptomeningeal disease from solid tumors: current clinical outcomes and future opportunities155
CAR T-cell therapy for B-cell lymphomas: outcomes and resistance mechanisms117
Clonal tracking in cancer and metastasis112
The functions and modifications of tRNA-derived small RNAs in cancer biology91
Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective79
Obesity and cancer76
The impact of tumor microenvironment: unraveling the role of physical cues in breast cancer progression76
Regulation of dormancy during tumor dissemination: the role of the ECM71
New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions58
Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?55
Progression and metastasis of small cell lung carcinoma: the role of the PI3K/Akt/mTOR pathway and metabolic alterations52
CAR T-cell therapy to treat multiple myeloma: current state and future directions51
Targeting lipid metabolism in cancer: neuroblastoma50
The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer50
The paradoxical role of inositol in cancer: a consequence of the metabolic state of a tumor48
Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives48
A multidisciplinary perspective on the complex interactions between sleep, circadian, and metabolic disruption in cancer patients45
Cell-cell interactions mediating primary and metastatic breast cancer dormancy42
p73 isoforms meet evolution of metastasis41
KISS1 metastasis suppressor in tumor dormancy: a potential therapeutic target for metastatic cancers?40
TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond39
Healthcare disparities, screening, and molecular testing in the changing landscape of non–small cell lung cancer in the United States: a review37
Preface35
Biography—Mathieu Boissan, Pharm.D., Ph.D35
LGR5: An emerging therapeutic target for cancer metastasis and chemotherapy resistance33
Targeting microRNAs as a promising anti-cancer therapeutic strategy against traffic-related air pollution-mediated lung cancer33
Neuropeptide Y in cancer—biological functions and potential clinical implications32
Biographies31
How circulating tumor cluster biology contributes to the metastatic cascade: from invasion to dissemination and dormancy31
Role of Neuropilin-2-mediated signaling axis in cancer progression and therapy resistance31
1.4278647899628